iBio, Inc.
IBIO
$1.04
-$0.03-2.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.39% | 33.62% | -- | 46.85% | 30.58% |
| Total Depreciation and Amortization | 3.96% | 4.27% | -- | -11.08% | -12.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.51% | -94.95% | -- | -85.94% | -43.02% |
| Change in Net Operating Assets | -32.25% | 100.36% | -- | -105.83% | 42.45% |
| Cash from Operations | -52.49% | 4.92% | -- | 17.79% | 30.43% |
| Capital Expenditure | -- | 99.52% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3,109.96% | -- | -- | -- | -- |
| Cash from Investing | -3,114.45% | 131.25% | -- | -- | 1,326.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 3.61% | 85.23% | -- | -58.88% | 69.26% |
| Issuance of Common Stock | 8,000.00% | -83.16% | -- | -99.56% | -99.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 6,863.64% | -- | -- | -- |
| Cash from Financing | 28,930.25% | -37.04% | -- | -103.80% | -106.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 717.79% | -54.84% | -- | -473.89% | -12.28% |